Intermune Inc Asset Turnover Ratio (ITMN), as of second quarter 2014, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Intermune Inc  (ITMN)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Intermune Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Intermune Inc asset turnover ratio, the ability of Intermune Inc's assets to generate revenue in the second quarter 2014, increased sequentially to 0.2 in the second quarter (Jun 30 2014), yet the ratio remained below the average, as ITMN's position remain challenging.

Within sector 26 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2014 compared to the preceding quarter from 2619 to 2726.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ITMN Asset Turnover Ratio (Jun 30 2014)
II. Quarter		 (Mar 31 2014)
I. Quarter		 (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter
Y / Y Asset Change 42.97 % -36.38 % 27.28 % 1.55 % 1.43 %
Y / Y Revenue Change 148.19 % 187.5 % 212.47 % 161.72 % 160.02 %
Asset Turnover Ratio (TTM) 0.2 0.18 0.12 0.09 0.07
ITMN's Total Ranking # 2726 # 2619 # 3044 # 2622 # 2617
Seq. Asset Change -6.32 % 48.6 % 13.42 % -9.45 % -58.31 %
Seq. Revenue Change 18.05 % 17.84 % 30.29 % 36.93 % 36.75 %



Asset Turnover Ratio Company Ranking
Within: No.
Healthcare Facilities Industry # 27
Healthcare Sector # 254
Overall Market # 2726

Asset Turnover Ratio Statistics
High Average Low
5.74 5.18 4.71
(Jun 30 2013)   (Jun 30 2012)




ITMN Company Profile • Back to ITMN Efficiency Comparisons • Compare ITMN Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2014, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2014 Assets at quarter ending Jun 30 2014
Supernus Pharmaceuticals inc   0.47 $ 50.347  Millions$ 106.617  Millions
Veracyte Inc   0.47 $ 28.585  Millions$ 60.851  Millions
Abbott Laboratories  0.46 $ 19,709.000  Millions$ 42,555.619  Millions
Medtronic Plc  0.46 $ 17,196.000  Millions$ 37,299.000  Millions
Remedent Inc   0.46 $ 2.822  Millions$ 6.134  Millions
Bristol myers Squibb Company  0.46 $ 16,206.000  Millions$ 35,580.750  Millions
Thermogenesis Holdings Inc   0.45 $ 15.987  Millions$ 35.216  Millions
Beam Therapeutics Inc   0.45 $ 1,933.246  Millions$ 4,274.097  Millions
Angiodynamics Inc   0.44 $ 354.425  Millions$ 796.927  Millions
Allergan plc  0.44 $ 7,848.000  Millions$ 17,729.814  Millions
Agilent Technologies inc   0.44 $ 4,723.000  Millions$ 10,682.500  Millions
Durect Corp  0.44 $ 18.129  Millions$ 41.118  Millions
Bio techne Corp  0.44 $ 357.763  Millions$ 812.611  Millions
Statera Biopharma Inc fka Cytocom Inc   0.44 $ 7.404  Millions$ 16.819  Millions
Inergetics Inc  0.44 $ 1.778  Millions$ 4.040  Millions
Nanostring Technologies Inc   0.44 $ 38.141  Millions$ 87.129  Millions
Boston Scientific Corporation  0.44 $ 7,220.000  Millions$ 16,575.000  Millions
Teva Pharmaceutical Industries Limited  0.43 $ 20,535.000  Millions$ 47,244.750  Millions
Teleflex Incorporated  0.43 $ 1,770.986  Millions$ 4,075.834  Millions
Rock Creek Pharmaceuticals, Inc.  0.43 $ 5.957  Millions$ 13.791  Millions
Sunwin Stevia International Inc.  0.43 $ 13.993  Millions$ 32.460  Millions
Alerislife Inc   0.42 $ 2,980.773  Millions$ 7,060.571  Millions
Medicines Co  0.42 $ 720.294  Millions$ 1,718.663  Millions
Merck and Co Inc   0.42 $ 43,550.000  Millions$ 104,596.000  Millions
Dyax Corp  0.41 $ 64.252  Millions$ 155.532  Millions
Macrogenics Inc   0.40 $ 59.077  Millions$ 145.913  Millions
Halozyme Therapeutics Inc   0.40 $ 58.863  Millions$ 147.919  Millions
Spero Therapeutics Inc   0.38 $ 5.788  Millions$ 15.064  Millions
Tearlab Corp  0.38 $ 17.855  Millions$ 47.386  Millions
Epizyme Inc.  0.37 $ 74.972  Millions$ 199.943  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.